Skip to main content
Cutia Therapeutics logo

Cutia Therapeutics — Investor Relations & Filings

Ticker · 2487 ISIN · KYG2606C1006 HKEX Manufacturing
Open in API
Filings indexed 178 across all filing types
Latest filing 2023-06-09 Governance Information
Country HK Hong Kong
Listing HKEX 2487

About Cutia Therapeutics

http://www.cutiatx.com

Cutia Therapeutics is an R&D-driven biopharmaceutical platform established in 2019, specializing in the research, development, manufacture, and commercialization of dermatological treatments. The company is dedicated to providing a comprehensive suite of innovative, safe, and effective solutions for patients and consumers. Its core therapeutic focus areas include the management of localized adipose accumulation and various scalp diseases. As a dermatology-focused entity, Cutia maintains a dedicated pipeline emphasizing novel candidates, including those targeting the Immune System domain.

Recent filings

Filing Released Lang Actions
Terms of Reference for the Audit Committee
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference for the Audit Committee of Cutia Therapeutics' and details the constitution, membership, duties, authority, and procedures of the Audit Committee. It does not contain any financial statements, audit results, or financial performance data. Instead, it outlines governance and procedural rules related to the audit committee's role and responsibilities. This type of document is a governance-related report focusing on internal rules and committee duties rather than an audit report or annual report. Therefore, it fits best under Governance Information (CGR). The document length is substantial and contains detailed governance content, supporting this classification with high confidence.
2023-06-09 English
FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is titled 'Fifth Amended and Restated Memorandum and Articles of Association' of Cutia Therapeutics, adopted by special resolution on 30 May 2023. It contains detailed company constitutional documents including the Memorandum of Association and Articles of Association, definitions, share capital details, and governance provisions. There is no financial data, earnings information, or management discussion of financial results. The document is a legal and governance document setting out the company's internal rules and structure. This fits the definition of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance documents, not a brief announcement or notice. Therefore, the correct classification is CGR with high confidence.
2023-06-09 English
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
Regulatory Filings Classification · 95% confidence The document is an announcement from the Hong Kong Stock Exchange (HKEX) regarding the 'IPO Allotment Results' for Cutia Therapeutics. It provides links to various documents related to the initial public offering (IPO) process, such as the cover, summary, and lists of successful applicants. Since this is an announcement regarding the publication of IPO-related materials and results rather than a financial report or a specific corporate governance document, it falls under the category of Regulatory Filings (RNS) as a general regulatory announcement.
2023-06-09 English
GLOBAL OFFERING
Capital/Financing Update Classification · 95% confidence The document is a landing page or index for a 'Global Offering' prospectus for Cutia Therapeutics (02487) on the HKEX news platform. It lists various sections of a prospectus, including 'Financial Information', 'Accountants' Report', and 'Structure of the Global Offering'. Since this is an announcement/index page providing links to the various components of a new share offering/IPO prospectus, it falls under the category of a regulatory filing related to capital raising.
2023-05-31 English
Documents on Display
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2023-05-31 English
GREEN APPLICATION FORM
Capital/Financing Update Classification · 95% confidence The document is an application form for a Hong Kong public offering of shares by Cutia Therapeutics, including detailed terms about the global offering, number of shares, offer price, and legal disclaimers. It references the prospectus dated May 31, 2023, and includes instructions for applying for shares under the Hong Kong Public Offering. The content is related to the initial public offering (IPO) process and share subscription, not a financial report, earnings release, or management discussion. It is not a report or announcement of voting results, board changes, or legal proceedings. The document is a formal application form for share subscription in a public offering, which falls under capital raising activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is not a brief announcement but a detailed application form related to financing.
2023-05-31 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.